You are here: Industry Insights > Epilepsy

News List

Purified CBD May Help Treat Drug-Resistant Epilepsy drugs
December 26, 2019
Among patients with tuberous sclerosis complex (TSC), the reduction in the frequency of TSC-associated seizures was greater in those receiving a purified version of cannabidiol (CBD) than ...
Sudden Death Can Occur Even in Well-Controlled Epilepsy drugs
June 21, 2019
Sudden Death Can Occur Even in Well-Controlled Epilepsy.
Epilepsy Drug Pregabalin (Lyrica) Tied to Higher Risk of Suicidal Behavior in Young Users drugs
June 14, 2019
Epilepsy Drug Pregabalin (Lyrica) Tied to Higher Risk of Suicidal Behavior in Young Users.
FDA Approves NAYZILAM® to Treat Seizure Activity in People Living with Epilepsy americanpharmaceuticalreview
May 22, 2019
UCB announced the U.S. Food and Drug Administration (FDA) has approved a New Drug Application for the company's newest anti-epileptic drug (AED) NAYZILAM® (midazolam) nasal spray CIV ...
Microsoft provides grant to develop Epilepsy prediction device biospectrumasia
May 21, 2019
The grant will help develop a seizure warning system
Eisai seeks EMA approval for Fycompa to treat epilepsy in paediatrics pharmaceutical-technology
February 15, 2019
Eisai has submitted an application to the European Medicines Agency (EMA) seeking approval for the use of its Fycompa (perampanel) medicine to treat paediatric patients suffering with epilepsy....
Epilepsy Foundation Awards $300,000 in Grants to Support Development of Epilepsy Treatments americanpharmaceuticalreview
January 23, 2019
The Epilepsy Foundation has awarded New Therapy Commercialization Grants totaling $300,000 to scientists with the goal of accelerating the development of therapies for those living with poorly controlled seizures.
FDA approves first generic version of Sabril to help treat seizures in adults and pediatric patients with epilepsy firstwordpharma
January 17, 2019
The U.S. Food and Drug Administration approved the first generic version of Sabril (vigabatrin) 500 mg tablets for treating complex partial seizures, also called focal seizures, as an adjunctive therapy (given with another primary treatment) in patients 1
NHS U-turns on Afinitor for TSC-related epilepsy pharmaphorum
December 25, 2018
NHS England has reversed a previous decision and will be funding Novartis’ Afinitor (everolimus) for TSC-related refractory epilepsy from April 2019.
Cannabis-based compound may reduce seizures in children with epilepsy worldpharmanews
December 06, 2018
Interest has been growing in the use of cannabinoids - the active chemicals in cannabis or marijuana - for the treatment of epilepsy in children.

Previous page 1 2 3 4 5 6 Next page